Portfolio Rationales: February 2026 (Copy)

19 Mar

Written By Fedor Kolchin

Please see our monthly reporting for February

Portfolio Rationales - February 2026

Portfolio Rationales - March 2026 (Copy)

Top Picks: Vaxcyte (PCVX) (Copy)